Latest Annual Reports
by Mike Gee
09 July 2026









































Black Hawk Acquisition Corp
REVENUE
$2,245,067
-9.90%
INCOME
$1,329,557
-30.60%
EMPLOYEES
N/A
CUSTOMERS
N/A
The Company (a special purpose acquisition company) holds substantial assets in trust and reported net income of $1,329,557 for 2025.
View Company PageFiled: 2026-03-06
Bridger Aerospace Group Holdings, Inc.
REVENUE
$122,830,000
24.56%
INCOME
$4,140,000
126.59%
EMPLOYEES
235
CUSTOMERS
3
Bridger Aerospace Group Holdings, Inc. provides aerial wildfire surveillance, relief and suppression, and airframe modification/MRO services using advanced aviation technology and sustainable methods, primarily serving federal and state government agencies.
View Company PageFiled: 2026-03-06
Amprius Technologies, Inc.
REVENUE
$73,011,000
202.11%
INCOME
-$44,000,000
1.50%
EMPLOYEES
109
CUSTOMERS
500
Amprius Technologies develops and commercializes high-energy silicon-anode lithium-ion batteries (SiCore and SiMaxx) for aviation, unmanned systems, light electric vehicles and other mobility applications using proprietary silicon-anode technology and an outsourced manufacturing model.
View Company PageFiled: 2026-03-06
BKV Corp
REVENUE
$1,008,809,000
73.64%
INCOME
$174,844,000
222.38%
EMPLOYEES
N/A
CUSTOMERS
58,000
BKV Corporation is an integrated energy company focused on upstream natural gas production, midstream gathering/processing/transportation, natural gas-fired power generation, and carbon capture, utilization and sequestration (CCUS) using a closed-loop model to optimize costs and reliability across the value chain.
View Company PageFiled: 2026-03-06
BC Partners Lending Corp
REVENUE
$19,881,000
12.09%
INCOME
$3,737,000
111.85%
EMPLOYEES
N/A
CUSTOMERS
62
BC Partners Lending Corporation is a U.S. middle‑market credit investment company organized as a BDC and RIC that originates and manages debt investments in private U.S. middle‑market companies.
View Company PageFiled: 2026-03-06
Bluejay Diagnostics, Inc.
REVENUE
N/A
INCOME
-$6,848,483
11.26%
EMPLOYEES
6
CUSTOMERS
N/A
Bluejay Diagnostics is a pre-revenue medical diagnostics company developing the Symphony near-patient analyzer and single-use cartridges, focused initially on a rapid IL-6 test for sepsis in critical care settings.
View Company PageFiled: 2026-03-06
Atlantis Glory Inc.
REVENUE
N/A
INCOME
-$39,199
3.16%
EMPLOYEES
N/A
CUSTOMERS
N/A
Company with no reported revenue in the provided periods, reporting net losses and operating activities funded by related-party financing.
View Company PageFiled: 2026-03-06
ARES INDUSTRIAL REAL ESTATE INCOME TRUST Inc.
REVENUE
$592,329,000
12.63%
INCOME
-$161,953,000
-24.25%
EMPLOYEES
N/A
CUSTOMERS
440
AIREIT is a publicly offered industrial real estate REIT that owns, manages, and finances a large portfolio of U.S. industrial properties (primarily distribution warehouses), invests in real estate-related debt and securities, and raises capital through ongoing equity offerings and a private DST program under an UPREIT structure with Advisor-based management and NAV-based share pricing.
View Company PageFiled: 2026-03-06
AUDDIA INC.
REVENUE
N/A
INCOME
-$7,693,197
11.80%
EMPLOYEES
5
CUSTOMERS
N/A
Auddia Inc. is an AI-powered audio technology company in Boulder, Colorado operating the consumer faidr app and the artist-facing Discovr Radio, transitioning from a B2C subscription model to a B2B SaaS model for AI-driven music discovery and artist promotion.
View Company PageFiled: 2026-03-06
Bunker Hill Mining Corp.
REVENUE
N/A
INCOME
-$93,132,015
-267.51%
EMPLOYEES
40
CUSTOMERS
N/A
Bunker Hill Mining Corp. (BHMC) is a Nevada corporation focused on restarting and developing the 100%‑owned Bunker Hill Mine in Kellogg, Idaho to produce zinc, lead, and silver concentrates, targeting a restart in the first half of 2026.
View Company PageFiled: 2026-03-06
Ares Real Estate Income Trust Inc.
REVENUE
$498,835,000
19.48%
INCOME
-$127,186,000
-121.80%
EMPLOYEES
N/A
CUSTOMERS
N/A
NAV-based perpetual-life REIT that raises capital through private stock and DST offerings to acquire and manage a diversified portfolio of U.S. and select international real estate and real-estate-related assets, with day-to-day management provided by an external Advisor.
View Company PageFiled: 2026-03-06
Altimmune, Inc.
REVENUE
$41,000
105.00%
INCOME
-$88,093,000
7.33%
EMPLOYEES
N/A
CUSTOMERS
700
Altimmune, Inc. is a late clinical-stage biopharmaceutical company developing pemvidutide, a balanced 1:1 glucagon/GLP-1 dual receptor agonist primarily for MASH with parallel programs in AUD and ALD.
View Company Page